New major order from India

Bactiguard has received a new order from India of some 60 000 Foley catheters
for infection prevention.
The initial order from India, which was received in December 2015, consisted of
some 50 000 Foley catheters for infection prevention (BIP Foleys). The new order
consists of some 60 000 BIP Foleys and will generate direct sales revenues of
approximately 2 million SEK at product delivery.

“Sales and marketing activities in India are ongoing with a high level of
intensity. There is a major need for infection prevention, as the level of multi
resistant bacteria is high. Our products are now reaching hospitals and
patients, where they are put to good use. As deliveries to dealers and hospitals
are increasing, our distributor needs to restock its inventory, which is
encouraging”, says Cecilia Edström, Vice President Sales & New Business.

This is information that Bactiguard Holding AB (publ) is required to publish in
compliance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on 10
August, 2016, at 08.00.

For further information, please contact:

Cecilia Edström, Vice President Sales & News business +46 72 226 23 28
About Bactiguard

Bactiguard is a Swedish medtech company with a global presence, offering a
solution that prevents healthcare associated infections caused by medical
devices. By preventing infections, we contribute to a reduced use of antibiotics
and the spread of multi-resistant bacteria, which is a growing problem
worldwide. We save lives, increase patient safety and significantly reduce the
cost for the healthcare and society. Our technology is well-proven, safe and
tissue friendly and consist of a thin layer of noble metals that prevents
bacterial growth. The coating can be applied on almost all medical devices.
Bactiguard-coated urinary catheters are market leading in the US and Japan and
the company has also its own product portfolio consisting of Foley catheters,
central venous catheters and endotracheal tubes. Bactiguard is a growth company,
focused on markets in Europe, Middle East, Asia and Latin America. The company
has about 60 employees worldwide, mainly at the headquarters in Stockholm and
the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more
about Bactiguard at www.bactiguard.com